循環腫瘍細胞市場規模、シェア、成長分析：技術別、用途別、製品別、検体別、最終用途別、地域別 - 産業予測 2025～2032年

循環腫瘍細胞の世界市場規模は2023年に122億米ドルと評価され、2024年の135億5,000万米ドルから2032年には314億6,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは11.1％で成長する見通しです。

世界の循環腫瘍細胞（CTC）市場は、がん診断における技術革新とがん罹患率の増加により、ダイナミックな成長を遂げています。非侵襲的診断ツール、特にCTC分析への需要は、個別化医療へのシフトとがんの早期発見への差し迫ったニーズが後押ししています。しかし、技術的な複雑さや標準化の欠如といった課題が、より広範な普及を妨げています。現在のところ、ELISA法とPCR法が製品の主流を占めています。北米が大きな市場シェアを占めているのは、その強固なヘルスケアインフラに起因しています。同市場は、進化する医療情勢に対応し、患者の転帰を向上させることを目的とした継続的な研究イニシアチブ、共同研究、革新的な製品開発によって特徴付けられています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

循環腫瘍細胞市場規模：技術別& CAGR（2025-2032）

• 市場概要
• CTC検出および濃縮方法
  • 免疫捕捉（ラベルベース）
  • ポジティブセレクション
  • ネガティブセレクション
  • サイズによる分離（ラベルフリー）
  • 膜ベース
  • マイクロ流体ベース
  • 密度に基づく分離（ラベルフリー）
  • 組み合わせた方法
• CTC直接検出法
  • SERS
  • 顕微鏡検査
  • その他
• CTC分析

循環腫瘍細胞市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 臨床/液体生検
  • リスクアセスメント
  • スクリーニングとモニタリング
• 調査
  • がん幹細胞と腫瘍形成の調査
  • 医薬品・治療法の開発

循環腫瘍細胞市場規模：製品別& CAGR（2025-2032）

• 市場概要
• キットと試薬
• 採血管
• デバイスまたはシステム

循環腫瘍細胞市場規模：検体別& CAGR（2025-2032）

• 市場概要
• 血液
• 骨髄
• その他の体液

循環腫瘍細胞市場規模：最終用途別& CAGR（2025-2032）

• 市場概要
• 調査・学術機関
• 病院と診療所
• 診断センター

循環腫瘍細胞市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
• 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Sysmex Corporation（Japan）
• Bio-Techne Corporation（USA）
• Thermo Fisher Scientific Inc.（USA）
• Miltenyi Biotec GmbH（Germany）
• Biolidics Limited（Singapore）
• ScreenCell（France）
• Greiner Bio-One International GmbH（Austria）
• AVIVA Biosciences（USA）
• BIOCEPT, Inc.（USA）
• Ikonisys, Inc.（USA）
• Epic Sciences（USA）
• Rarecells Diagnostics（France）
• STEMCELL Technologies, Inc.（Canada）
• Precision for Medicine（USA）
• ANGLE plc（UK）
• Creatv MicroTech, Inc.（USA）

結論と提言

Global Circulating Tumor Cell Market size was valued at USD 12.2 billion in 2023 and is poised to grow from USD 13.55 billion in 2024 to USD 31.46 billion by 2032, growing at a CAGR of 11.1% during the forecast period (2025-2032).

The global Circulating Tumor Cell (CTC) market is witnessing dynamic growth, driven by innovations in cancer diagnostics and an increasing incidence of cancer. The demand for non-invasive diagnostic tools, particularly CTC analysis, is fueled by a shift towards personalized medicine and a pressing need for early cancer detection. However, challenges such as technological complexities and the lack of standardization hinder broader adoption. Currently, ELISA and PCR-based methods dominate the product landscape. North America commands a significant market share attributed to its robust healthcare infrastructure. The market is characterized by continuous research initiatives, collaborative efforts, and innovative product developments aimed at addressing the evolving medical landscape and enhancing patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Circulating Tumor Cell market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Circulating Tumor Cell Market Segments Analysis

Global Circulating Tumor Cell Market is segmented by Technology, Application, Product, Specimen, End Use and region. Based on Technology, the market is segmented into CTC detection & enrichment methods, CTC Direct Detection Methods and CTC Analysis. Based on Application, the market is segmented into Clinical/ Liquid Biopsy and Research. Based on Product, the market is segmented into Kits & Reagents, Blood Collection Tubes and Devices or Systems. Based on specimen, the market is segmented into Blood, Bone Marrow and Other Body Fluids. Based on End Use, the market is segmented into Research and academic institutes, Hospital and clinics and Diagnostic centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Circulating Tumor Cell Market

The rising incidence of cancer worldwide has intensified the demand for advanced diagnostic tools, with circulating tumor cell (CTC) analysis gaining prominence as a non-invasive and valuable technique for cancer detection and monitoring. Additionally, the focus on personalized medicine and the urgency for early cancer diagnosis are driving the adoption of CTC technologies. This growing need for effective diagnostic solutions is reshaping the global landscape of cancer management and treatment, fostering innovation and advancements in the CTC market, which aims to provide better outcomes for patients through improved detection and monitoring capabilities.

Restraints in the Global Circulating Tumor Cell Market

One of the primary challenges facing the global circulating tumor cell (CTC) market is the technological complexity involved in CTC analysis. This intricacy complicates the process and highlights the need for standardization across various methodologies, which hinders widespread acceptance and implementation. Furthermore, concerns regarding the reliability and reproducibility of CTC results create additional barriers, making it difficult for these techniques to be integrated into standard clinical practices. As such, these factors collectively contribute to limiting the overall growth and adoption of CTC technologies in the healthcare sector, restraining market potential.

Market Trends of the Global Circulating Tumor Cell Market

The global circulating tumor cell (CTC) market is witnessing a significant trend characterized by the increasing integration of CTC analysis into routine clinical practice. This shift is driven by the technology's ability to facilitate real-time cancer progression tracking and treatment response evaluation. Advances in innovative technologies such as microfluidic systems and sophisticated molecular detection techniques are enhancing the precision and sensitivity of CTC analysis. Additionally, the rising awareness and adoption of liquid biopsy methods for cancer diagnostics underscore the critical role of CTCs as valuable biomarkers. This convergence of technology and clinical application is poised to revolutionize cancer care and diagnosis.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Circulating Tumor Cell Market Size by Technology & CAGR (2025-2032)

• Market Overview
• CTC detection & enrichment methods
  • Immunocapture (label-based)
  • Positive selection
  • Negative selection
  • Size-based separation (label-free)
  • Membrane-based
  • Microfluidic-based
  • Density-based separation (label-free)
  • Combined methods
• CTC Direct Detection Methods
  • SERS
  • Microscopy
  • Others
• CTC Analysis

Global Circulating Tumor Cell Market Size by Application & CAGR (2025-2032)

• Market Overview
• Clinical/ Liquid Biopsy
  • Risk Assessment
  • Screening and Monitoring
• Research
  • Cancer stem cell & tumorogenesis research
  • Drug/therapy development

Global Circulating Tumor Cell Market Size by Product & CAGR (2025-2032)

• Market Overview
• Kits & Reagents
• Blood Collection Tubes
• Devices or Systems
• Global Circulating Tumor Cell Market Size by Specimen & CAGR (2025-2032)
• Market Overview
• Blood
• Bone Marrow
• Other Body Fluids

Global Circulating Tumor Cell Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Research and academic institutes
• Hospital and clinics
• Diagnostic centers

Global Circulating Tumor Cell Market Size & CAGR (2025-2032)

• North America (Technology, Application, Product, Specimen, End Use)
  • US
  • Canada
• Europe (Technology, Application, Product, Specimen, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Application, Product, Specimen, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Application, Product, Specimen, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Application, Product, Specimen, End Use)
  • GCC Countries
• South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biolidics Limited (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScreenCell (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Greiner Bio-One International GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AVIVA Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOCEPT, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ikonisys, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Epic Sciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rarecells Diagnostics (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STEMCELL Technologies, Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Precision for Medicine (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ANGLE plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creatv MicroTech, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations